[go: up one dir, main page]

DE602005011041D1 - Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort - Google Patents

Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort

Info

Publication number
DE602005011041D1
DE602005011041D1 DE602005011041T DE602005011041T DE602005011041D1 DE 602005011041 D1 DE602005011041 D1 DE 602005011041D1 DE 602005011041 T DE602005011041 T DE 602005011041T DE 602005011041 T DE602005011041 T DE 602005011041T DE 602005011041 D1 DE602005011041 D1 DE 602005011041D1
Authority
DE
Germany
Prior art keywords
subject
hormon
vaccine
growth
releases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005011041T
Other languages
English (en)
Inventor
Ruxandra Draghia-Akli
Patrica A Brown
Amir S Khan
William C Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advisys Inc
Original Assignee
Advisys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advisys Inc filed Critical Advisys Inc
Publication of DE602005011041D1 publication Critical patent/DE602005011041D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602005011041T 2004-07-23 2005-07-21 Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort Expired - Lifetime DE602005011041D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59073904P 2004-07-23 2004-07-23
PCT/US2005/025747 WO2006014737A2 (en) 2004-07-23 2005-07-21 Growth hormone releasing hormone enhances the immune response induced by vaccination

Publications (1)

Publication Number Publication Date
DE602005011041D1 true DE602005011041D1 (de) 2008-12-24

Family

ID=35717476

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005011041T Expired - Lifetime DE602005011041D1 (de) 2004-07-23 2005-07-21 Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort

Country Status (10)

Country Link
US (1) US20060025368A1 (de)
EP (1) EP1809336B1 (de)
JP (1) JP2008507537A (de)
CN (1) CN101027081A (de)
AT (1) ATE413890T1 (de)
AU (1) AU2005269724B2 (de)
DE (1) DE602005011041D1 (de)
MX (1) MX2007000893A (de)
NZ (1) NZ553274A (de)
WO (1) WO2006014737A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7846720B2 (en) * 2005-01-26 2010-12-07 Vgx Pharmaceuticals, Inc. Optimized high yield synthetic plasmids
CN101778643B (zh) * 2007-05-21 2013-05-22 塞莱克蒂斯股份有限公司 用于向哺乳动物皮肤输送多核苷酸的方法和装置
CN102083457B (zh) * 2008-05-28 2018-05-08 Vgx制药有限公司 天花dna疫苗及其引起免疫应答的抗原
CN108707589B (zh) * 2018-06-07 2021-11-26 西南民族大学 一种牛病毒性腹泻病毒SMU-Z6/1a/SC/2016分离株及其应用
CN116328742B (zh) * 2023-04-27 2024-08-30 大连理工大学 一种核壳型磁性分子印迹聚合物材料、制备方法及应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223019A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4228156A (en) * 1979-03-30 1980-10-14 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223020A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4226857A (en) * 1979-03-30 1980-10-07 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4224316A (en) * 1979-03-30 1980-09-23 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4228158A (en) * 1979-03-30 1980-10-14 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223021A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4410512A (en) * 1981-12-28 1983-10-18 Beckman Instruments, Inc. Combinations having synergistic pituitary growth hormone releasing activity
US5134120A (en) * 1984-08-03 1992-07-28 Cornell Research Foundation, Inc. Use of growth hormone to enhance porcine weight gain
US5036045A (en) * 1985-09-12 1991-07-30 The University Of Virginia Alumni Patents Foundation Method for increasing growth hormone secretion
ZA872532B (en) * 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
US4833166A (en) * 1987-05-01 1989-05-23 Grosvenor Clark E Growth hormone releasing hormone complementary peptides
US4839344A (en) * 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
USRE33699E (en) * 1987-07-09 1991-09-24 International Minerals & Chemical Corp. Growth hormone-releasing factor analogs
FR2622455B1 (fr) * 1987-11-04 1991-07-12 Agronomique Inst Nat Rech Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes
US5023322A (en) * 1988-08-31 1991-06-11 Mta Kutatas-Es Szervezetelemzo Intezete Analogs of growth hormone releasing factor (GRF) and a method for the preparation thereof
US5084442A (en) * 1988-09-06 1992-01-28 Hoffmann-La Roche Inc. Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
US5134210A (en) * 1989-07-27 1992-07-28 Edwards Bill R Acrylic resin composition
US5137872A (en) * 1989-09-18 1992-08-11 Pitman-Moore, Inc. Growth hormone-releasing factor analogs
AU656144B2 (en) * 1990-06-29 1995-01-27 F. Hoffmann-La Roche Ag Histidine substituted growth hormone releasing factor analogs
US5486505A (en) * 1990-07-24 1996-01-23 Polygen Holding Corporation Polypeptide compounds having growth hormone releasing activity
AU662731B2 (en) * 1991-04-09 1995-09-14 F. Hoffmann-La Roche Ag Growth hormone releasing factor analogs
US5663146A (en) * 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
US5298422A (en) * 1991-11-06 1994-03-29 Baylor College Of Medicine Myogenic vector systems
US5439440A (en) * 1993-04-01 1995-08-08 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US5702359A (en) * 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
US5792747A (en) * 1995-01-24 1998-08-11 The Administrators Of The Tulane Educational Fund Highly potent agonists of growth hormone releasing hormone
JPH11503454A (ja) * 1995-04-14 1999-03-26 ジ アドミニストレイターズ オブ ザ チューレン エデュケイショナル ファンド 成長ホルモン放出因子の類似体
WO1998048832A1 (en) * 1997-05-01 1998-11-05 Protechtion Unlimited, Inc. Nerve growth factor as a vaccine adjuvant
EP1052286A3 (de) * 1999-04-12 2001-07-25 Pfizer Products Inc. Wachstumshormon- (GH) und Wachstumshormon-freisetzenden Hormon (GHRH) enthaltende Zusammensetzungen
US20020058039A1 (en) * 2000-04-27 2002-05-16 Coyne Michael J. Method of measuring the duration of adequate immune memory in companion animals
JP2005519035A (ja) * 2001-12-07 2005-06-30 インターツェル・アクチェンゲゼルシャフト 免疫促進性オリゴデオキシヌクレオチド
MXPA04005713A (es) * 2001-12-11 2005-06-06 Baylor College Medicine Complemento de la hormona de liberacion de la hormona de crecimiento para tratar sujetos cronicamente enfermos.
MXPA04011766A (es) * 2002-05-28 2005-03-31 Advisys Inc SUMINISTRO AUMENTADO DE UNA CONSTRUCCION DE áCIDO NUCLEICO IN VIVO POR EL SISTEMA DE POLO-L-GLUTAMATO (PLG).

Also Published As

Publication number Publication date
EP1809336A2 (de) 2007-07-25
ATE413890T1 (de) 2008-11-15
EP1809336B1 (de) 2008-11-12
WO2006014737A2 (en) 2006-02-09
NZ553274A (en) 2010-02-26
AU2005269724B2 (en) 2011-03-10
AU2005269724A1 (en) 2006-02-09
CN101027081A (zh) 2007-08-29
WO2006014737A3 (en) 2006-05-11
US20060025368A1 (en) 2006-02-02
MX2007000893A (es) 2007-04-18
JP2008507537A (ja) 2008-03-13

Similar Documents

Publication Publication Date Title
Embregts et al. Oral vaccination of fish: Lessons from humans and veterinary species
Esser et al. Tetanus vaccination with a dissolving microneedle patch confers protective immune responses in pregnancy
RU2010149495A (ru) Новые адъювантные композиции
MXPA03011815A (es) Vacuna de micoplasma bovis y metodos para reducir la neumonia en animales.
AR061930A1 (es) Mimeticuerpos de glp-1 humanos, composiciones, metodos y usos
WO2006113622A3 (en) Direct vaccination of the bone marrow
UA110328C2 (en) Recombinant vaccine based on avian paramixoviruses and method for its preparation and administration
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
WO2002081621A3 (fr) Vaccin contre le virus de la fievre du nil
DE602005011041D1 (de) Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort
Mansoor et al. Intranasal delivery of nanoparticles encapsulating BPI3V proteins induces an early humoral immune response in mice
EP2899203A3 (de) Leishmania impfstoff unter verwendung von sandmücke speichelimmunogen
Chen et al. Biotechnologies applied in biomedical vaccines
ATE442857T1 (de) Vakzine zusammensetzung zur impfung von hunden gegen infektiöse atemwegserkrankung bei hunden (cird)
JP2012533557A (ja) 舌上ワクチン及びアプリケーター
TWI378144B (en) Recombinant plasmic containing multicopy cpg motifs and transformant thereof for applying on dna adjuvant in avian vaccines
RU2010143584A (ru) Вакцина для защиты от haemophilus parasuis серотипа 4 у поросят
RU2002115519A (ru) Способ вакцинопрофилактики эпидемического паротита на крайнем севере
Vos et al. Maternal immunity against rabies in raccoon dogs
ATE332920T1 (de) Nukleinsäureimpfstoff bestehend aus einem fusionsprotein, dass eine adjuvanssequenz von einem planzenvirushüllprotein aufweist
UA96923C2 (ru) Вакцина на основе lawsonia и способы ее применения
Schrupp et al. Effect of Vaccinating Pre-Weaned Dairy Calves on Cell Mediated Immune Function
ATE540693T1 (de) Impfung und impfstoffe gegen hundeherpesvirus
Pons Goin'Ballistic Against Brucellosis
Lin et al. Development of a Multivalent Bacterial Vaccine for Vibrio alginolyticus, V. parahaemolyticus and Photobacterium damselae Subspecies piscicida and Its Evaluation in Cobia(Rachycentron canadum)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition